Lymphoma-CLL/SLL
Primary Site | Histology | Behavior |
---|---|---|
C000-C440, C442-C689, C691-C694, C698-C699, C739-C750, C754-C809 | 9823 | <Any value> |
C700-C729, C751-C753 | 9823 | 3 |
Notes
9823 (EXCEPT C441, C690, C695-C696) **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 79 *Hodgkin and Non-Hodgkin Lymphomas*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. * Chapter 80 *Pediatric Hodgkin and Non-Hodgkin Lymphomas*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schema for the listed primary sites * C441, C690, C695-C696 (9823): *Lymphoma Ocular Adnexa* **Note 3:** Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL/SLL) is always staged as a lymphoma. **Note 4:** The Cotswold modification of the Ann Arbor staging system (used in AJCC 6th and 7th editions) has been updated to the *Lugano classification*. The *Lugano classification* includes an E suffix for lymphoma with either localized extralymphatic presentations (Stage IE) or by contiguous spread from nodal disease (Stage IIE). A change from the Cotswold modification of the Ann Arbor Staging System, E lesions do not apply to patients with Stage III nodal disease; or any patient with nodal disease above and below the diaphragm with concurrent contiguous extralymphatic involvement (Stage IV), which was previously Stage IIIE. **Note 5:** In addition to coding EOD Primary Tumor, the following data items are also needed to assign a stage group for CLL/SLL. * Lymphocytosis * Adenopathy * Organomegaly * Anemia * ThrombocytopeniaData Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
Tumor Size Clinical | 999 | No |
NAACCR #752
tumorSizeClinical |
None | |
Tumor Size Pathological | 999 | No |
NAACCR #754
tumorSizePathologic |
None | |
Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
EOD Regional Nodes | 888 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
EOD Mets | 88 | Yes |
NAACCR #776
eodMets |
None | |
SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
Grade Clinical | 8 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
Grade Pathological | 8 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
B Symptoms | 8 | No |
NAACCR #3812
bSymptoms |
CCCR/Canada COC SEER |
SSDI |
HIV Status | 8 | No |
NAACCR #3859
hivStatus |
COC 2018–2020 SEER |
SSDI |
NCCN International Prognostic Index (IPI) | X8 | No |
NAACCR #3896
nccnInternationalPrognosticIndex |
COC SEER |
SSDI |
Lymphocytosis | <BLANK> | Yes |
NAACCR #3885
lymphocytosis |
All | SSDI |
Adenopathy | <BLANK> | Yes |
NAACCR #3804
adenopathy |
All | SSDI |
Organomegaly | <BLANK> | Yes |
NAACCR #3907
organomegaly |
All | SSDI |
Anemia | <BLANK> | Yes |
NAACCR #3811
anemia |
All | SSDI |
Thrombocytopenia | <BLANK> | Yes |
NAACCR #3933
thrombocytopenia |
All | SSDI |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Schema ID | 00795 |
NAACCR #3800
schemaId |
None | |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
Derived Rai Stage | <BLANK> |
NAACCR #3955
derivedRaiStage |
SSDI | |
Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |